Verrica Pharmaceuticals Downgraded by Royal Bank of Canada
Nov 5, 2024
Pharmaceuticals Investment Portfolios
BridgeBio Pharma Reveals Long-Term Efficacy Data for Acoramidis at AHA Scientific Sessions
Oct 3, 2024
Liquidia Corporation Expands Partnership with Pharmosa Biopharm to Advance Inhaled Treprostinil Therapy
Oct 3, 2024
SciSparc Advances with FDA Approval on Phase IIb Clinical Trial for Tourette Syndrome Therapy
Sep 30, 2024
Enliven Therapeutics Reports Promising Outcomes in Phase 1 Trial of ELVN-001 for Chronic Myeloid Leukemia
Sep 29, 2024
Zydus Gains USFDA Approval for Enzalutamide Capsules, Positive Signal for Investors
Sep 29, 2024
Cytokinetics Showcases Further SEQUOIA-HCM Trial Data at HCMS Scientific Sessions
Sep 28, 2024
Sanofi's Dupixent Becomes First Biologic Approved in the US for COPD With Eosinophilic Phenotype
Sep 28, 2024
Organon Expands Dermatology Portfolio with Acquisition of Dermavant's VTAMA® Cream
Sep 19, 2024
Organon Expands Dermatology Portfolio with Acquisition of Dermavant's VTAMA® Cream
Sep 19, 2024
SciSparc and Clearmind Medicine Announce Patent for Breakthrough MDMA-Inspired Therapy
Sep 7, 2024
Strides Pharma Science Gains USFDA Approval for Generic Theophylline ER Tablets
Sep 7, 2024
Praxis Precision Medicines Gears Up for Phase 2 Results of Its Pioneering Epileptic Encephalopathies Treatment
Sep 3, 2024
MIRA Pharmaceuticals Experiences Pre-Market Surge; Spotlight on Premarket Movers
Aug 27, 2024
Eugia Pharma Under USFDA Scrutiny for Manufacturing Issues
Aug 25, 2024
SciSparc and Clearmind Medicine Advance Potential Obesity Treatment Through MEAI Research
Aug 7, 2024
Corbus Pharmaceuticals CEO to Present at August Investor Conferences
Jul 31, 2024
Aarti Drugs Receives EIR for Baddi Unit from USFDA, Solidifying Its Position in Pharmaceutical Sector
Jul 30, 2024
Ventyx Biosciences Faces Setback as Crohn's Disease Drug Candidate VTX958 Fails Phase 2 Trial
Jul 29, 2024
Lipella Pharmaceuticals Embarks on Phase 2a Clinical Trial for Oral Lichen Planus Treatment with LP-310
Jul 29, 2024
GENFIT Announces EMA Support for Iqirvo® in PBC Treatment
Jul 27, 2024
U.S. Health Officials Recommend RSV Vaccinations for Seniors, Pfizer in Spotlight
Jun 27, 2024
Sanofi's Dupixent Shows Promise for Young EoE Patients in Phase 3 Trials
Jun 27, 2024
Eli Lilly and Co Partners with OpenAI to Advance Antimicrobial Research
Jun 26, 2024
INHALE-3 Study Highlights the Efficacy of Inhaled Insulin Over Usual Care for Type 1 Diabetes
Jun 23, 2024
Obesity Drug Shows Potential in Treating Sleep Apnea
Jun 22, 2024
Glenmark Pharma Secures USFDA Approval for Heartburn Medicine
Jun 12, 2024
Lilly's Tirzepatide Shows Promising Results in MASH Resolution and Fibrosis Improvement
Jun 9, 2024
FDA Approves IMDelltra™ (Tarlatamab-DLLe), a Novel T-Cell Engager Therapy for Extensive-Stage Small Cell Lung Cancer
May 17, 2024
Quoin Pharmaceuticals Sets Date for Q1 2024 Financial Results
May 3, 2024
Amgen Prepares for Teprotumumab Application Submission to EMA
Apr 27, 2024
The Impact of Weight Loss Drugs on Traditional Dieting Approaches
Apr 25, 2024
Groundbreaking Lebrikizumab Study Shows Promising Results for Atopic Dermatitis in Skin of Color
Mar 11, 2024
Athira Pharma Shares Insightful Data on Fosgonimeton for Alzheimer's and Parkinson's Treatment at AD/PD™ 2024
Mar 9, 2024
Incannex's Groundbreaking CannQuit-N Moves Forward After Positive Pre-IND Meeting with the FDA
Feb 17, 2024
Eli Lilly's New Treatments Propel Stock Price Predictions
Feb 16, 2024
Cognition Therapeutics' Research Elucidates Key Proteins in Alzheimer’s Therapy
Feb 7, 2024
Silo Pharma Sets Its Sights on 2024 with Focus on Mental Health, Chronic Pain, and Neurological Disorders
Feb 2, 2024
Corbus Pharmaceuticals Set to Present Phase 1 Clinical Data of SYS6002 at 2024 ASCO GU
Jan 23, 2024
BioNTech and DualityBio Start Key Phase 3 Trial for Metastatic Breast Cancer Treatment
Jan 23, 2024
Johnson & Johnson Acquires Ambrx Biopharma, Enhancing Cancer Drug Portfolio Amidst Harpoon Therapeutics Advancements
Jan 9, 2024
Arcutis Canada's Roflumilast Foam 0.3% Advances in Health Canada Submission for Seborrheic Dermatitis Treatment
Jan 9, 2024
Clearmind Medicine and SciSparc's Strategic Endeavor in 2023 to Advance Psychedelic Treatments
Jan 5, 2024
Why Vertex Pharmaceuticals VRTX Could Be A Soaring Investment
Dec 10, 2023
Cytokinetics' Reldesemtiv Fails in COURAGE-ALS Study, Shares CYTK Affected
Dec 8, 2023
Health Canada Grants Approval to LITFULO™ as First Severe Alopecia Areata Treatment in Canada
Dec 5, 2023
India and US Enhance Collaboration in Pharma, Minerals, and Emerging Technologies
Dec 2, 2023
SciSparc Achieves Breakthrough in Weight Loss and Metabolic Disorder Treatment with Psychedelic-Based Therapy
Nov 29, 2023
Athira Pharma Showcases Neuroprotective Benefits of Fosgonimeton in Alzheimer's Research
Nov 15, 2023
GENFIT Announces Phase III Elafibranor Trial Results for PBC, Showcased at AASLD and Featured in NEJM
Nov 14, 2023
SciSparc Ltd. Announces Promising Phase IIb Trial Results for SCI-110 in Tourette Syndrome
Nov 14, 2023
Theseus Pharmaceuticals Embarks on Strategic Review to Enhance Shareholder Value
Nov 14, 2023
SciSparc's SCI-110 Shows Promise in Phase IIb Trial for Tourette Syndrome
Nov 13, 2023
SciSparc's SCI-110 Shows Promise in Phase IIb Trial for Tourette Syndrome
Nov 13, 2023
Ampio Pharmaceuticals AMPE Enters the Spotlight with Analyst Coverage Initiation
Nov 12, 2023
ANI Pharmaceuticals Receives 'Buy' Rating Upgrade from StockNews.com
Nov 12, 2023
Nova Cannabis Inc. and Indivior PLC Showcase Significant Q3 2023 Financial Results amid Cannabis Sector Growth
Nov 11, 2023